Main Menu
Menu

News

Publish Date
PREVAIL Act Narrowly Moves Forward Despite Concerns About Drug Pricing Impact
  • IPWatchdog
  • Eileen McDermott
In Tight Vote, Senate Panel OKs Bill To Set New PTAB Limits
  • Law360
  • Ryan Davis
USPTO’s Final Rule on FY 2025 Patent Fees Drops Divisive Proposals for Across-the-Board Hikes
  • IPWatchdog
  • Eileen McDermott
Avoiding counterfeits during the online shopping season
  • Arizona's Family
  • Susan Campbell and Gary Harper
IDEA Act Moves Forward While Fate of PERA and PREVAIL Seems Uncertain
  • IPWatchdog
  • Eileen McDermott
What’s next for US IP policy with Trump back in the Oval Office and a red Senate?
  • IAM
  • Angela Morris
IP Organizations Want More on USPTO’s AI Patent Eligibility Guidance
  • IPWatchdog
  • Eileen McDermott and Steve Brachmann
USPTO Told More Clarity Needed On AI And Patent Eligibility
  • Law360
  • Ryan Davis
Patent Quality Report Finds Improper Patent Abandonment is Greater Issue Than Improper Grants
  • IPWatchdog
  • Steve Brachmann
Nonprofit Finds Bad Patent ‘Epidemic’ Is Just A Myth
  • Law360
  • Dani Kass
IPWatchdog LIVE 2024 Day One Highlights Need for IP Community to Stand Up to Recent Attacks
  • IPWatchdog
  • Eileen McDermott
Universities, VCs, Startups and More Express Support for Trio of Pro-Patent Bills in Congress
  • IPWatchdog
  • Steve Brachmann
Scroll to Top